Andante FM (First Mover)

<aside> <img src="/icons/stars_blue.svg" alt="/icons/stars_blue.svg" width="40px" />

Pipelines

1. Next-generation Peptide Antibiotics (first-in class) : ADT-340 and ADT-117

Overcomimg the major causes of antibiotic failure by the strong bactericidal action of peptide antibiotics

(Antimicrobial resistance, lack of broad-spectrum antibacterial effect, antibiotic tolerance and biofilm formation)

o A new peptide backbone and novel molecular targets (the non-proteogenic lipids)

o Low chance of antibiotic tolerance (a bactericidal effect on both growing and non-growing bacteria)

o Low chance of biofilm formation (Kills bacteria within a short time)

o Target bacteria : CRPA, CRAB, MRSA and VRSA

o Indication (IV) :  Severe pneumonia and concurrent secondary bloodstream infections caused by MDR bacteria or bacteremia (sepsis)

1. ADT-338 (skin)  : Wound and foot ulcer
2. MRSA Diagnosis

ADT-602, 604, 607 or 609 :  MRSA/VRSA detection in blood (Timearound : 2-5 h)

1. ADT-601  : Rapid test kit for bacteria in drinking water and swimming pool </aside>

<aside> <img src="/icons/stars_blue.svg" alt="/icons/stars_blue.svg" width="40px" /> 2022. 03. Company establishment (start-up at Korea University)

</aside>

Overview

Peptide Antibiotics

MRSA diagnostics (진단)

Bacterial Detection in Water (진단)

PDC (Peptide-drug Conjugates for Cancer Treatment)

CEO’s Message (인사말)

History (연혁)

Contact Us

Address : 서울 성동구 성수동 2가 제이제이 빌딩 3064 호

Tel : 02-539-6940

Address : JJ building 3064, Seongsu-dong 2-ga , Seongdong-gu, Seoul, Korea

Phone : +82 2-539-6940

E-mail : [email protected] or [email protected]